These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 18394347)

  • 41. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion.
    Ai L; Wang W; Li J; Ye T; Li Y
    Am J Med Sci; 2024 Aug; 368(2):136-142. PubMed ID: 38583522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion.
    Wagner IC; Guimarães MJ; da Silva LK; de Melo FM; Muniz MT
    J Bras Pneumol; 2007; 33(2):185-91. PubMed ID: 17724538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of multidimensional data analysis for prediction of lung malignity.
    Mrázová V; Mocák J; Varmusová E; Kavková D; Bednárová A
    J Pharm Biomed Anal; 2009 Sep; 50(2):210-5. PubMed ID: 19467816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
    Eskelinen M; Kataja V; Hämäläinen E; Kosma VM; Penttilä I; Alhava E
    Anticancer Res; 1997; 17(2B):1231-4. PubMed ID: 9137478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.
    Shitrit D; Zingerman B; Shitrit AB; Shlomi D; Kramer MR
    Oncologist; 2005 Aug; 10(7):501-7. PubMed ID: 16079317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
    Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of serum anti-p53 antibody assay for lung cancer diagnosis.
    Park Y; Kim Y; Lee JH; Lee EY; Kim HS
    Arch Pathol Lab Med; 2011 Dec; 135(12):1570-5. PubMed ID: 22129186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
    Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
    Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC
    Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnositic values of combined determination of carbohydrate antigen and tissue polypeptide antigen and neuron-specific enolase and carcinoembryonic antigen in the malignant pleural effusion].
    Wang Q; Zhang S; Gu S; Ma Y; Jia H
    Zhongguo Fei Ai Za Zhi; 2002 Feb; 5(1):44-7. PubMed ID: 21315029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
    Wang B; He YJ; Tian YX; Yang RN; Zhu YR; Qiu H
    Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relation between the serum tissue polypeptide specific antigen level and the biological demeanour of lung cancer].
    Chen M; Liu J; Yu W; Lu B; Dai Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 May; 25(5):262-4. PubMed ID: 12133315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Carcinoembryonic antigen assay in serum and pleural effusion of pulmonary malignancies and benign lesions].
    Jiang XF; Zhu YJ; Zhao WL; Ma X; Lo WC
    Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):430-1. PubMed ID: 3582109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of serum CYFRA 21-1 in lung cancer.
    Muraki M; Tohda Y; Iwanaga T; Uejima H; Nagasaka Y; Nakajima S
    Cancer; 1996 Apr; 77(7):1274-7. PubMed ID: 8608502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
    Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
    Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
    Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C
    An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer.
    Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Kameyama M; Suehiro S
    Ann Thorac Surg; 2007 Jan; 83(1):216-21. PubMed ID: 17184666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma.
    Yan HJ; Wang RB; Zhu KL; Jiang SM; Zhao W; Xu XQ; Feng R
    Chin Med J (Engl); 2012 Apr; 125(8):1410-5. PubMed ID: 22613644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.